David Campbell | BiotechTV

top of page

Dec 7, 2024

Janux's CEO David Campbell reviews this week's data from JANX007, the company's PSMA x CD3 masked bispecific for prostate cancer

He describes how the improvement over data from earlier this year gives him confidence in the strength of the signal he sees in this...

Taking a deep dive into last week's T-cell engager data with the CEO of Janux Therapeutics

Mar 6, 2024

Company News

Taking a deep dive into last week's T-cell engager data with the CEO of Janux Therapeutics

David Campbell explains how Janux has used masking technology to improve the profile T-cell engagers in solid tumors.

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

At Savills, the Life Sciences Team specializes in helping biotech companies unlock their full potential by aligning real estate strategies with their scientific and business goals. As a leading global commercial real estate advisory firm, we focus exclusively on occupier services and tenant representation, acting as a trusted partner to some of the most innovative companies in the industry.

Visit Saville's Life Sciences Overview